Research output per year
Research output per year
Personal profile
Public Profile
Dr Shanmuganathan is a clinical and laboratory haematologist, conducting her PhD in leukaemia genomics. Not only is she a clinical research fellow at SAHMRI but she continues to consolidate her clinical experience as the Leukaemia Fellow at the Royal Adelaide Hospital. She is currently a recipient of the Dawes scholarship from the Royal Adelaide Hospital.
Education/Academic qualification
Fellowship of the Royal Australasian College of Physicians
Award Date: 1 Feb 2016
Fellowship of the Royal College of Pathologists of Australia
Award Date: 1 Feb 2016
Bachelor's Degree, University of Adelaide
Award Date: 1 Dec 2007
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
-
Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia
Thomson, D. W., Shahrin, N. H., Wang, P. P. S., Wadham, C., Shanmuganathan, N., Scott, H. S., Dinger, M. E., Hughes, T. P., Schreiber, A. W. & Branford, S., 1 Aug 2020, In: Leukemia. 34, 8, p. 2051-2063 13 p.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus) -
Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission
Pagani, I. S., Dang, P., Saunders, V. A., Grose, R., Shanmuganathan, N., Kok, C. H., Carne, L., Rwodzi, Z., Watts, S., McLean, J., Braley, J., Altamura, H., Yeung, D. T., Branford, S., Yong, A. S. M., White, D. L., Hughes, T. P. & Ross, D. M., Apr 2020, In: Leukemia. 34, 4, p. 1052-1061 10 p.Research output: Contribution to journal › Article › peer-review
10 Citations (Scopus) -
Successful treatment-free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells
Irani, Y. D., Hughes, A., Clarson, J., Kok, C. H., Shanmuganathan, N., White, D. L., Yeung, D. T., Ross, D. M., Hughes, T. P. & Yong, A. S. M., 1 Nov 2020, In: British Journal of Haematology. 191, 3, p. 433-441 9 p.Research output: Contribution to journal › Article › peer-review
5 Citations (Scopus) -
What's NEXT for CML-NGS mutation screening
Shanmuganathan, N. & Hughes, T. P., 20 Feb 2020, In: Blood. 135, 8, p. 515-516 2 p.Research output: Contribution to journal › Editorial › peer-review
-
Bone marrow fibrosis associated with long-term imatinib therapy: Resolution after switching to a second-generation TKI
Shanmuganathan, N., Branford, S., Hughes, T. & Hiwase, D., 12 Feb 2019, In: Blood Advances. 3, 3, p. 370-374 5 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)